Form 4: Humana Director Kurt J. Hilzinger Increases Equity Stake Through RSU Conversion

Humana Inc. Director Kurt J. Hilzinger reported an increase in his beneficial ownership of company stock units through the conversion of a cash fee into restricted stock units.

Summary

• Kurt J. Hilzinger, a Director of Humana Inc. (HUM), reported changes in his beneficial ownership of company securities.
• He directly owns 19,448 shares of Humana Common Stock.
• He holds 24,034 Restricted Stock Units (RSUs) derived from annual director's fees, which are deferred at his election until his resignation and will be payable on a 1-for-1 basis in Humana Inc. common stock. This amount includes 783 restricted stock units from the Company's 2019 Amended & Restated Plan.
• An additional 2,753 Restricted Stock Units were acquired from director's dividend payments reinvested into stock units on vested and deferred stock units, also deferred until his resignation and payable 1-for-1 in common stock.
• On June 30, 2025, Mr. Hilzinger acquired 399 Restricted Stock Units by electing to convert a director's cash fee into stock units at a price of $242.815 per unit. These units are also deferred until his resignation and payable 1-for-1.
• Following the acquisition of 399 units, his beneficial ownership of this specific category of Restricted Stock Units (from cash fee conversion) is 15,044 units.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The filing indicates a director's continued accumulation of equity in the company through compensation mechanisms, which generally signals confidence and aligns insider interests with shareholders. There are no negative disclosures.

Positives

• A director, Kurt J. Hilzinger, increased his beneficial ownership in Humana Inc. through the conversion of a cash fee into 399 restricted stock units, further aligning his interests with shareholders.
• The deferral of stock unit payments until the director's resignation indicates a long-term commitment and focus on sustained company performance.

Future Outlook

The filing indicates a continued long-term alignment of a director's compensation with the company's equity performance, as stock units are deferred until resignation.

Management Comments

• Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, per the Director's election.

Industry Context

This Form 4 filing is a routine disclosure of insider equity transactions, common across all publicly traded companies. It reflects a standard practice of compensating directors with equity, aligning their interests with long-term shareholder value, which is prevalent in the healthcare industry and beyond.

Comparison to Industry Standards

• The practice of compensating directors with restricted stock units (RSUs) and allowing for deferral until resignation is a common corporate governance practice among large-cap companies, including peers in the healthcare sector such as UnitedHealth Group (UNH) or CVS Health (CVS), as it promotes long-term alignment.
• The conversion of cash fees into equity, as seen with the 399 RSUs, is a mechanism often employed to further incentivize directors to focus on sustained company performance, a standard seen across various industries.

Corporate Governance

Stakeholder Impact

• Shareholders: The director's increased equity stake through compensation aligns his interests with long-term shareholder value.
• Management: The compensation structure incentivizes long-term strategic focus and performance.

Next Steps

• The acquired restricted stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon the reporting person's resignation of services as a director.

Key Dates

Recommendation

Keywords

Humana Inc., HUM, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Director Compensation, Equity Compensation, Healthcare